An interventional study of Toric intraocular lens Zeiss AT TORBI in Cataract Bilateral and Astigmatism Bilateral, sponsored by University of Plymouth. Recruiting at 1 site in United Kingdom. Open to participants aged 50 Years to 75 Years. Per ClinicalTrials.gov, last updated 2024-03-28.
Sponsored by University of Plymouth · Not applicable, Interventional, and Treatment
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
Among 39 studies in Cataract with a site in United Kingdom — 8 open to participants now, 8 under way, 1 of them phase 3. Cataract · United Kingdom.
Among the 39 studies in Cataract with a site in United Kingdom, this one is the 11th largest by planned enrollment of the 29 interventional ones that give a count, is one of 2 that started in 2024, is one of 23 with no phase, and was the 27th registered.
1,633 studies on the registry are indexed under Cataract; 234 are open to participants now.
Browse Cataract studies →8 of the 39 studies in Cataract with a site in United Kingdom are open now. Recruiting first, the newest first:
Carl Zeiss Meditec AG · Sites in United Kingdom, Czechia, Germany and 1 more country
Ages 18+
Alcon Research · Sites in United Kingdom
Ages 18+
Queen's University, Belfast · Sites in United Kingdom
Ages 50+
Vision Care Collective Limited · Sites in United Kingdom
Ages 18+
iSTAR Medical · Sites in United Kingdom, Panama, Spain
Ages 40+
A study can be open while its sites in United Kingdom have not opened yet or have stopped. Only those recruiting at a site in United Kingdom →
Of the 143 Cataract studies recruiting now, 88 (62%) set no upper age limit and 8 (6%) stop at 75 or younger; 10 take children under 18; 15 take healthy volunteers.
This study: 50 Years to 75 Years · all sexes · no healthy volunteers.
The full table on the hub →This tab as a report to print or save as PDF → With an account.
39 studies; the count open now beside each. This study's row is marked.
First in 2007; this study’s year is marked. 2 started in 2024.
This study's planned enrollment of 140 is above the median of 79 across 1,094 interventional studies indexed under Cataract.
Median enrollment 100 across the 29 interventional studies, 157 across the 10 observational. Of the 20 that completed or were terminated, 7 (35%) have results posted.
This tab as a report to print or save as PDF → With an account.
12 of 39 have an industry lead sponsor. The 10 most frequent:
University of Plymouth is the lead sponsor of 49 studies on the registry; 16 are open to participants now.
University of Plymouth has 4 studies filed under Cataract — fewer than ten, so there is no comparison to draw.
1 of the studies in Cataract with a site in United Kingdom that are under way reach primary completion within a year, 0 of them phase 3. Phase 3 first, then by date:
| Study | Primary completion |
|---|---|
| NCT07228091Alcon ResearchSurgical Procedure Efficiency Evaluation stuDy | 2027-06 |
Add it to your calendar (.ics) → With an account.
Among the 39 studies in Cataract with a site in United Kingdom, from their registry updates:
This tab as a report to print or save as PDF → With an account.
Cataracts are the major cause of blindness in the world. Cataract surgery, being the most performed surgery in the world today, provide correction by extracting the natural lens from its capsular bag and replaced by an artificial intraocular lens (IOL) implantation. In the UK, almost all patients undergoing cataract surgery by the NHS are given monofocal intraocular lenses (IOLs) which do not correct corneal astigmatic error. It is estimated that around 20% of the population has over 1.50DC of corneal astigmatism. Uncorrected astigmatism not only increase spectacle dependency and reduce quality of life post surgically, but it also adversely affects the overall economic costs. Specialised toric IOLs offer the opportunity to correct pre-existing corneal astigmatism. Previous work has shown a link between reduced vision and balance or mobility. Full correction of refractive error may have greater impact on lifestyle than previously thought.
This is a single centre, parallel randomized controlled trial study comparing the dynamic stability and visual outcomes of cataract patient with astigmatism implanted with mono-focal Toric versus non-Toric IOLs.
140 cataracts patients with astigmatism awaiting cataract correction surgery at the Royal Eye infirmary of the University Hospitals of Plymouth NHS Trust will be recruited in this study over a two year period. The participants will be randomly assigned to be implanted with either Toric IOLs or standard non-Toric IOLs. Three additional study visits will be arranged for them. One visit before the cataract surgery, second visit at three to six months after the first eye cataract surgery and third visit at three to six months after the second eye cataract surgery. The primary assessment outcome is dynamic balance measured by movement sensors (accelerometer) during walk and turn, crossing over obstacle and stair walking. The secondary outcomes include eye tracking during movement activities, visual functions, risk of fall questionnaires and vision-specific quality of life questionnaire.
This project is funded by Carl Zeiss Meditec AG, led by the University of Plymouth and sponsored by University Hospitals Plymouth NHS Trust . The project also involves collaboration with the University of Glasgow and the Plymouth Marjon University.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.
You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.
Informed consent
Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.
You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Toric intraocular lens- AT TORBI® 709M, to be implanted bilaterally in the cataract surgery to correct astigmatism at the same time.
Device: Toric intraocular lens Zeiss AT TORBI
Standard monofocals IOLs- Zeiss CT ASPHINA 409/509M, to be implanted bilaterally in the standard NHS cataract surgery without correcting the astigmatism.
Device: Toric intraocular lens Zeiss AT TORBI
Intraocular lenses are medical devices that are implanted in patients during cataract surgery. At Plymouth University NHS trust the standard lens is a monofocal non-Toric lens unless the patient has astigmatism greater than 4.00D. This study involves implantation of a toric lens in the intervention group where astigmatism is greater than 1.00D. The lens is called the toric IOLS- Zeiss AT TORBI, will be implanted bilaterally instead of standard monofocal IOLs- Zeiss CT ASPHINA, used in routine cataract surgery within NHS.
Also known as: Monofocal non-toric intraocular lens Zeiss CT ASPHINA 409/509M
Jerk from the centre of mass Visit 1
Assessed during functional activities using accelerometers
Time frame: Baseline assessment will be carried out at study visit 1 before the cataract surgery
Jerk from the centre of mass Visit 2
Assessed during functional activities using accelerometers
Time frame: First reassessment will be carried out at study visit 2 around 3-6 months after the first cataract IOL replacement surgery
Jerk from the centre of mass Visit 3
Assessed during functional activities using accelerometers
Time frame: Final reassessment at study visit 3 around 3-6 months after the second eye cataract IOL replacement surgery
Unaided vision Visit 1
Unaided vision measured on a LogMAR acuity chart
Time frame: Baseline assessment will be carried out at study visit 1 before the cataract surgery
Unaided visionVisit 2
Unaided vision measured on a LogMAR acuity chart
Time frame: First reassessment will be carried out at study visit 2 around 3-6 months after the first cataract IOL replacement surgery
Unaided vision Visit 3
Unaided vision measured on a LogMAR acuity chart
Time frame: Final reassessment at study visit 3 around 3-6 months after the second eye cataract IOL replacement surgery
Visual acuity Visit 1
Aided vision measured on a LogMAR acuity chart
Time frame: Baseline assessment will be carried out at study visit 1 before the cataract surgery
Visual acuity Visit 2
Aided vision measured on a LogMAR acuity chart
Time frame: First reassessment will be carried out at study visit 2 around 3-6 months after the first cataract IOL replacement surgery
Visual acuity Visit 3
Aided vision measured on a LogMAR acuity chart
Time frame: Final reassessment at study visit 3 around 3-6 months after the second eye cataract IOL replacement surgery
Mean spherical refraction Visit 1
Mean spherical refraction assessed through subjective refraction
Time frame: Baseline assessment will be carried out at study visit 1 before the cataract surgery
Mean spherical refraction Visit 2
Mean spherical refraction assessed through subjective refraction
Time frame: First reassessment will be carried out at study visit 2 around 3-6 months after the first cataract IOL replacement surgery
Mean spherical refraction Visit 3
Mean spherical refraction assessed through subjective refraction
Time frame: Final reassessment at study visit 3 around 3-6 months after the second eye cataract IOL replacement surgery
Astigmatic power J0 Visit 1
J0 assessed through subjective refraction and expressed in vector form
Time frame: Baseline assessment will be carried out at study visit 1 before the cataract surgery
Astigmatic power J0 Visit 2
J0 assessed through subjective refraction and expressed in vector form
Time frame: First reassessment will be carried out at study visit 2 around 3-6 months after the first cataract IOL replacement surgery
Astigmatic power J0 Visit 3
J0 assessed through subjective refraction and expressed in vector form
Time frame: Final reassessment at study visit 3 around 3-6 months after the second eye cataract IOL replacement surgery
Astigmatic power J45 Visit 1
J45 assessed through subjective refraction and expressed in vector form
Time frame: Baseline assessment will be carried out at study visit 1 before the cataract surgery
Astigmatic power J45 Visit 2
J45 assessed through subjective refraction and expressed in vector form
Time frame: First reassessment will be carried out at study visit 2 around 3-6 months after the first cataract IOL replacement surgery
Astigmatic power J45 Visit 3
J45 assessed through subjective refraction and expressed in vector form
Time frame: Final reassessment at study visit 3 around 3-6 months after the second eye cataract IOL replacement surgery
Contrast sensitivity Visit 1
Contrast sensitivity measured in log units
Time frame: Baseline assessment will be carried out at study visit 1 before the cataract surgery
Contrast sensitivity Visit 2
Contrast sensitivity measured in log units
Time frame: First reassessment will be carried out at study visit 2 around 3-6 months after the first cataract IOL replacement surgery
Contrast sensitivity Visit 3
Contrast sensitivity measured in log units
Time frame: Final reassessment at study visit 3 around 3-6 months after the second eye cataract IOL replacement surgery
Rotation of IOL at visit 1
Rotation of IOL relative to operation
Time frame: Baseline assessment will be carried out at study visit 1 before the cataract surgery
Rotation of IOL at visit 2
Rotation of IOL relative to operation
Time frame: First assessment will be carried out at study visit 2 around 3-6 months after the first cataract IOL replacement surgery
Rotation of IOL at visit 3
Rotation of IOL relative to Operation
Time frame: Final reassessment at study visit 3 around 3-6 months after the second eye cataract IOL replacement surgery
Tilt of IOL at Visit 1
Tilt of IOL assessed using image analysis
Time frame: Baseline assessment will be carried out at study visit 1 before the cataract surgery
Tilt of IOL at Visit 2
Tilt of IOL assessed using image analysis
Time frame: assessment at study visit 3 around 3-6 months after the second eye cataract IOL replacement surgery
Tilt of IOL at Visit 3
Tilt of IOL assessed using image analysis
Time frame: assessment at study visit 3 around 3-6 months after the second eye cataract IOL replacement surgery
Centration of IOL at Visit 1
Centration of IOL assessed using image analysis
Time frame: Baseline assessment will be carried out at study visit 1 before the cataract surgery
Centration of IOL at Visit 2
Centration of IOL assessed using image analysis
Time frame: assessment at study visit 2 around 3-6 months after the first eye cataract IOL replacement surgery
Centration of IOL at Visit 3
Centration of IOL assessed using image analysis
Time frame: assessment at study visit 3 around 3-6 months after the second eye cataract IOL replacement surgery
Fear of falling
Fear of falling measured using revised fear of falling questionnaire (FFR)
Time frame: Baseline assessment will be carried out at study visit 1 before the cataract surgery
Fear of falling
Fear of falling measured using revised fear of falling questionnaire (FFR)
Time frame: assessment at study visit 2 around 3-6 months after the first eye cataract IOL replacement surgery
Fear of falling
Fear of falling measured using revised fear of falling questionnaire (FFR)
Time frame: assessment at study visit 3 around 3-6 months after the second eye cataract IOL replacement surgery
Risk of fall
Risk of fall in daily activities measured by Short Fall Efficacy Scale Questionnaire (Short FFS-I)
Time frame: Baseline assessment will be carried out at study visit 1 before the cataract surgery
Risk of fall
Risk of fall in daily activities measured by Short Fall Efficacy Scale Questionnaire (Short FFS-I)
Time frame: assessment at study visit 2 around 3-6 months after the first eye cataract IOL replacement surgery
Risk of fall
Risk of fall in daily activities measured by Short Fall Efficacy Scale Questionnaire (Short FFS-I)
Time frame: assessment at study visit 3 around 3-6 months after the second eye cataract IOL replacement surgery
Cataract related quality of life
Using Catract patient reported outcome measure CAT-PROM5 questionnaire
Time frame: Baseline assessment will be carried out at study visit 1 before the cataract surgery
Cataract related quality of life
Using Catract patient reported outcome measure CAT-PROM5 questionnaire
Time frame: assessment at study visit 2 around 3-6 months after the first eye cataract IOL replacement surgery
Cataract related quality of life
Using Catract patient reported outcome measure CAT-PROM5 questionnaire
Time frame: assessment at study visit 3 around 3-6 months after the second eye cataract IOL replacement surgery
PDFs hosted by the registry, ClinicalTrials.gov.
Plan to share: No — no plan to share IPD
Started Jan 2024 (actual). Primary completion is estimated for Dec 2024, 11 months after the start.
Of 304 non-industry interventional studies with no phase under Cataract, half reached primary completion within 18 months of starting (the median), counting those still running; a quarter within 7 and three quarters within 30. This study's planned 11 months is below that.
Counting every sponsor, half of 494 studies reached it within 17 months; a quarter within 9 and three quarters within 29.
How these figures are worked out, and which studies are left out of them.
Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.
Contact study teamGet an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
University of Plymouth